[{"id":"a154e2c7-3e0a-4a08-9d78-f38920d834dd","acronym":"LYMFOR","url":"https://clinicaltrials.gov/study/NCT06125028","created_at":"2023-11-09T16:12:55.005Z","updated_at":"2024-07-02T16:34:59.106Z","phase":"Phase 3","brief_title":"[68Ga]Ga-PentixaFor-PET Imaging for Staging of Marginal Zone Lymphoma","source_id_and_acronym":"NCT06125028 - LYMFOR","lead_sponsor":"Pentixapharm AG","biomarkers":" CXCR4","pipe":" | ","alterations":" CXCR4 expression • CXCR4 positive","tags":["CXCR4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CXCR4 expression • CXCR4 positive"],"overall_status":"Recruiting","enrollment":" Enrollment 148","initiation":"Initiation: 06/01/2024","start_date":" 06/01/2024","primary_txt":" Primary completion: 06/15/2025","primary_completion_date":" 06/15/2025","study_txt":" Completion: 06/15/2025","study_completion_date":" 06/15/2025","last_update_posted":"2024-06-04"}]